Home / Tag Archives: Diabetes management (page 3)

Tag Archives: Diabetes management

Can Bi-Hormonal Systems Finally Eliminate Severe Hypoglycemia?

dual-hormone-artificial-pancreas-severe-hypoglycemia

Many people with type 1 diabetes live with the constant fear of blood glucose dropping too low. Even today’s most advanced automated insulin delivery systems cannot actively raise glucose once levels begin to fall. Instead, they can only reduce or suspend insulin delivery. A dual-hormone artificial pancreas system changes that …

Read More »

Diabetic Eye Disease May Start Years Before Your Eye Exam Finds It

Patient undergoing advanced retinal imaging with OCT scan displaying early retinal changes associated with diabetic eye disease before visible diabetic retinopathy.

Diabetes affects far more than blood sugar. In fact, the earliest stages of diabetic retinal disease may begin years before an eye doctor can see the classic signs of diabetic retinopathy during a routine examination. Imagine a smoke detector that alerts you before you ever see flames. That is the …

Read More »

A Newly Discovered Form of Cell Death May Explain Why Diabetes Causes So Many Complications

Scientific illustration showing ferroptosis, an iron-dependent form of cell death, contributing to diabetic complications affecting the kidneys, eyes, nerves, and heart.

Diabetes is known for raising blood sugar levels, but its long-term complications often have the greatest impact on health. Kidney disease, vision loss, nerve damage, and cardiovascular disease affect millions of people living with diabetes. For years, researchers focused on inflammation, oxidative stress, and poor circulation to explain these complications. …

Read More »

Could Your “Type 2” Patient Actually Have a Different Disease? New Trial Challenges Diabetes Treatment

Endocrinologist discussing precision treatment options with a patient diagnosed with HNF1A-MODY while reviewing genetic testing and diabetes management results.

When a person develops diabetes at a young age, is not overweight, and has several family members with the condition, is it really type 2 diabetes? In many cases, the answer may be no. A growing body of evidence suggests that thousands of people worldwide are living with HNF1A-MODY, a …

Read More »

Farxiga Just Went Generic—Will Lower Prices Finally Change Diabetes Care?

Prescription bottle of generic dapagliflozin (Farxiga) beside a blood glucose meter, stethoscope, heart model, and kidney model representing diabetes, cardiovascular, and kidney care.

For many people living with type 2 diabetes, the biggest challenge is not finding an effective medication. It is being able to afford it. That reality may begin to change now that the U.S. Food and Drug Administration (FDA) has approved the first generic versions of Farxiga (dapagliflozin), potentially making …

Read More »

The “Graveyard Shift” Penalty: Why Night-Shift Workers Face a Hidden Diabetes Challenge

Healthcare worker on a night shift reviewing continuous glucose monitor data while managing diabetes during an overnight work schedule.

Night-shift work keeps hospitals, factories, transportation systems, and emergency services running around the clock. However, while society benefits from overnight workers, their metabolic health often pays the price. Recent continuous glucose monitoring (CGM) studies have shown that shift work is strongly associated with greater glycemic variability in people with diabetes, …

Read More »

Morning or Evening? New Research Suggests Exercise Timing May Change Diabetes Outcomes

Person exercising at sunrise and another exercising at sunset with a glucose meter and healthy meal, illustrating how exercise timing may affect blood sugar control in people with diabetes.

For years, diabetes care has emphasized one simple message: exercise regularly. While that advice remains essential, researchers are now asking a more specific question. Could when you exercise be just as important as how much you exercise? Emerging evidence suggests the answer may be yes. The growing field of chronotherapy, …

Read More »

The Hidden Cost of Diabetes Care: Why Treatment Burden Is Becoming a Clinical Outcome

Patient with diabetes reviewing medications, glucose monitoring supplies, and medical bills, illustrating the treatment burden associated with long-term diabetes care.

Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload …

Read More »

The Return of C-Peptide: Why This Old Biomarker Is Finding New Clinical Uses

Healthcare professional reviewing C-peptide test results with a pancreatic model, blood sample, and glucose monitoring equipment representing beta-cell function assessment in diabetes care.

For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …

Read More »

When Cardiology Meets Endocrinology: Why Diabetes Care Is Becoming a Team Sport

Multidisciplinary healthcare team including a cardiologist and endocrinologist collaborating on diabetes management with cardiovascular risk assessment in a modern clinical setting.

Not long ago, diabetes management focused primarily on controlling blood glucose levels. Today, that approach has evolved dramatically as cardiologists and endocrinologists increasingly work together to reduce cardiovascular risk. Thanks to groundbreaking cardiovascular outcome trials (CVOTs), clinicians now understand that treating type 2 diabetes means protecting the heart, kidneys, and …

Read More »